Elsevier

The Lancet

Volume 336, Issue 8721, 20 October 1990, Pages 955-959
The Lancet

MEDICAL SCIENCE
Contraceptive efficacy of testosterone-induced azoospermia in normal men

https://doi.org/10.1016/0140-6736(90)92416-FGet rights and content

Abstract

A multicentre study (ten centres) in seven countries was done to assess the contraceptive efficacy of hormonally-induced azoospermia in 271 healthy fertile men. Each subject received 200 mg testosterone enanthate weekly by intramuscular injection. 157 men (cumulative rate at 6 months 65%) became azoospermic in three consecutive semen samples. These men entered a 12-month efficacy phase during which continuing testosterone injections were the only form of contraception. There was 1 pregnancy during 1486 months of the efficacy phase (0·8 conceptions [95% confidence interval 0·02-4·5] per 100 person- years). Discontinuations from the study were mainly because azoospermia was not achieved within 6 months and because of dislike of the injection schedule. The mean time to become azoospermic was 120 days (SD 40); reappearance of spermatozoa was detected in 11 men and in no case led to discontinuation from the study or to pregnancy. After the testosterone injections had been stopped, the estimated median time from azoospermia to recovery (sperm concentration of at least 20 million/ml) was 3·7 months (3·6-3·9) and to the subject's mean baseline sperm concentration was 6·7 months (6·2-8·7). Hormonal regimens that induce azoospermia can provide highly effective, sustained, and reversible male contraception with minimum side-effects.

References (27)

  • Ja Ross et al.

    Voluntary sterilization: an international fact book

    (1985)
  • Wp Maudlin et al.

    Prevalence of contraceptive use: trends and issues

    Stud Fam Plan

    (1988)
  • Mj Rowley et al.

    Summary of studies utilizing androgens in the normal human male

  • Ca Paulsen et al.

    Male contraceptive development: re-examination of testosterone enanthate as an effective single agent

  • Rs Swerdloff et al.

    Clinical evaluation of testosterone enanthate in the reversible suppression of spermatogenesis in the human male: efficacy, mechanism of action and adverse effects

  • Sb Schearer et al.

    Hormonal contraception for men

    Int J Androl

    (1978)
  • A. Barfield et al.

    Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, depot medroxy progesterone acetate and testosterone esters

    Contraception

    (1979)
  • Dj Patanelli

    Hormonal control of male fertility

    (1978)
  • World Health Organisation

    Laboratory manual for the examination of human semen and semen-cervical mucus interaction

    (1987)
  • Wm Hunter et al.

    Reduction of non-specific serum responses in human pituitary gonadotrophin rachoimmunoassays

    J Endocrinol

    (1979)
  • Wj Bremner et al.

    Follicle stimulating hormone and human spermatogenesis

    J Clin Invest

    (1981)
  • Cs Corker et al.

    A radioimmunosassay for testosterone in various biological fluids without chromatography

    J Steroid Biochem

    (1978)
  • Cited by (492)

    • Male contraception

      2023, Progres en Urologie
    • Male contraceptive development: A medicinal chemistry perspective

      2022, European Journal of Medicinal Chemistry
    View all citing articles on Scopus
    View full text